Dr. Robert Gleeson, Executive Health Program Director, internal medicine physician
David Goldberg, MD, is an internal medicine physician with Froedtert The Medical College of Wisconsin. http://doctors.froedtert.com/PhysicianDirectory/Glee...

By: Froedtert

Link:

Dr. Robert Gleeson, Executive Health Program Director, internal medicine physician - Video

(l-r): Pete Fisher, Opry Vice President and General Manager; Dierks Bentley; Marty Stuart; Old Crow Medicine Show. Photo by Chris Hollo, courtesy of Schmidt Relations.

Modern-day string band Old Crow Medicine Show was formally inducted into the Grand Ole Opry last night by Opry members Dierks Bentley and Marty Stuart. Among the award-winning groups first performances in Nashville were on the sidewalks outside the Opry House in Summer 2000, playing for fans entering and exiting Opry performances. The band graduated to the Opry stage for its official Opry debut on Jan. 13, 2001, quickly became a fan favorite during dozens of Opry performances since, and was invited by Stuart to join the Opry on Aug. 16 in Cleveland, Ohio.

Just before show time, the band reprised its Opry Plaza performances from more than a dozen years ago, walking outside the Opry House and playing tunes including Brave Boys and Hesitation Blues for surprised fans waiting outside for the evenings Opry show.

Onstage later in the night, Opry Vice President and General Manager Pete Fisher and Opry members Dierks Bentley and Stuart took the stage alongside Old Crow Medicine Show, presenting the group with its Opry member award. Congratulations, Old Crow, on being a part of the coolest club there is, Bentley said.

Addressing the band, Marty added, You offer a whole new energy and love for country music in the 21st century.

Speaking on behalf of the group, Ketch Secor related that years ago members of the band asked themselves if theyd ever make it big in TV. Secor recalled having said, I dont know about TV, but we might make something of ourselves on radio. Fast forwarding to tonights show, Secor concluded, Were standing out here on the most beloved broadcast anywhere on earth. I think we made it big on radio! We, the Old Crows, are just so proud to be entrusted to carry on the traditions of the Grand Ole Oprys good-natured riot.

After tearing into the bands signature song, Wagon Wheel, (currently covered by fellow Opry member Darius Rucker) the group invited fellow Opry members Bentley, Stuart, Connie Smith, and the Del McCoury Band to join them on the standards Will The Circle Be Unbroken and I Saw The Light.

Old Crow has over the years become a favorite of Opry audiences and everyone backstage, as well, said Fisher. Its fun for so many of us that in many ways Old Crow looks and sounds a lot like some of the great early Opry bands like Roy Acuff and his Smoky Mountain Boysbands which helped propel the Opry to national prominence. Tonight represents a great full circle, and as the great Jimmy Dickens says, The circle cant be broken.

After the induction, the group added a plaque bearing its name to the Opry Member Gallery backstage at the Opry House.

Old Crow Medicine Show is scheduled to perform concerts on Dec. 30 and Dec. 31 at the Ryman Auditorium. Tickets will go on sale Sept. 27 at 10 a.m.

See original here:

Old Crow Medicine Show Inducted Into the Grand Ole Opry

WHAT: Penn Medicine will celebrate one of the largest capital projects in the history of Pennsylvania Hospital, the official opening of Penn Medicine Washington Square a new 153,000 square foot, green building in center city Philadelphia that serves as the major hub of outpatient care for Pennsylvania Hospital. This modern facility features leading-edge telecommunication and clinical information systems, providing patients with the most advanced level of collaborative and interdisciplinary care.

More than 100 providers from across a wide range of services including cardiology, concierge medicine, otorhinolaryngology, primary care, surgery and womens health are now available in one location along with patient pre-admission testing and phlebotomy services. The facility is also built atop an existing parking garage, offering added convenience for patients.

Penn Medicine Washington Square is an integral part of Pennsylvania Hospitals master plan which includes the expansion of private rooms for our patients. It represents great strides in both meeting the growing need for outpatient care and Penn Medicines overall commitment to its patients in Center City and beyond.

Tours of Penn Medicine Washington Square will be available and will include: a patient exam room, diagnostic space; patient waiting areas and lobbies; and the new Avenue C self-checkout vending market for employees.

**More information below

WHEN: Thursday, September 19, 2013 5:30 PM 7:00 PM Remarks to begin at 6:15 PM

WHERE: Penn Medicine Washington Square 800 Walnut Street Philadelphia, PA

WHO: Speakers & Special Guests

J. Larry Jameson, MD, PhD Executive Vice President, University of Pennsylvania for the Health System Dean, Perelman School of Medicine at the University of Pennsylvania

Amy Gutmann, PhD President, University of Pennsylvania

More:

Grand Opening of New Philadelphia Outpatient Medical Facility: Penn Medicine Washington Square

Public release date: 17-Sep-2013 [ | E-mail | Share ]

Contact: Bob Nellis newsbureau@mayo.edu 507-284-5005 Mayo Clinic

ROCHESTER, Minn.-- From Promise to Practice is the title and the main message of the second annual Individualizing Medicine Conference at Mayo Clinic, Sept. 30-Oct. 2. Physicians from more than 40 states and several countries will be arriving in Minnesota to hear and learn about the latest developments and research in genomic research and how to move these discoveries into the medical practice.

"Our goal is to inform practicing physicians, but other care providers, students, media and the public as well," says Richard Weinshilboum, M.D., chair of this year's conference held by Mayo Clinic's Center for Individualized Medicine. "Individualizing prevention, diagnosis and treatment is the core of medical genomics and the future of medicine. Even if you missed the last 13 years since the mapping of the human genome, we'll help you catch up in three days."

Opening keynote speaker on Monday, September 30, will be Eric Green, M.D., Ph.D., director of the National Institute of Genomic Health Research, Bethesda, M.D. Co-hosts for the conference will be Richard Besser, M.D., chief health and medical editor for ABC News and former acting director of the Centers for Disease Control, and Ceci Connolly, managing director of the Health Research Institute, PwC.

The conference offers expert speakers, focused breakout sessions, and real-life case studies so participants can discover and discuss emerging topics in medical genomics. Topics range from translating genomic findings into clinical care to communicating accurately and ethically with patients. Also this year, on Sunday Sept. 29, an "Omics 101" seminar will be offered at a lay level for those new to individualized medicine. This course is being offered separately and is ideal for students and media who will be working in or reporting on the genomics field.

Individualized medicine is a growing field of patient care based on the increasing knowledge of the human genome, mapped just a decade ago. Mayo Clinic is a leader in transferring medical genomics to medical practice clinomics as evidenced by its Individualized Medicine Clinic, launched a year ago. Mayo's Center for Individualized Medicine also includes programs in biomarker discovery, pharmacogenomics, epigenomics and the human microbiome.

Individualizing Medicine 2013 is supported by the Satter Foundation.

###

About Mayo Clinic

View post:

Mayo Clinic hosts NIH genomics director at Individualizing Medicine Conference

The growth of personalised medicine threatens the communal approach that has brought our biggest health gains

ADVOCATES of personalised medicine claim that healthcare isn't individualised enough.

Backed up by the glamour of new biotechnologies such as direct-to-consumer genetic testing, personalised medicine what I call "Me Medicine" appears to its advocates as the inevitable and desirable way to go. Barack Obama, when still a US senator, declared that "in no area of research is the promise greater than in personalised medicine".

This trend towards Me Medicine is led by the US, but it is growing across the developed world.

In contrast, "We Medicine" public-health programmes such as flu shots or childhood vaccination is increasingly distrusted and vulnerable to austerity cuts. Yet historically this approach has produced the biggest increase in lifespan. Even today, countries with more social provision of healthcare and less individualistic attitudes have better health outcomes across all social classes.

Contrary to the claims of its proponents, the personalised approach hasn't yet delivered a paradigm shift in medicine. A 2012 Harris poll of 2760 US patients and physicians found that doctors had recommended personal genetic tests for only 4 per cent of patients. The Center for Health Reform & Modernization, run by US healthcare company UnitedHealth, put the figure at just 2 per cent.

But money is still pouring into Me Medicine. In July, the UK government announced that it would offer private companies a subsidy from a 300 million fund to encourage investment in its personalised medicine initiative, Genomics England. Last year the US administration increased the National Institutes of Health budget for personalised medicine, while cutting the budget for the Centers for Disease Control and Prevention's Office of Public Health Genomics by 90 per cent.

Of course it would be nice if we could afford both, but in reality there's a growing risk that "me" will edge out "we". If it does, it won't be because the science is better or the outcomes more beneficial. In some instances of Me Medicine, clinical outcomes are worse than the We equivalent. For example, according to the UK's Royal College of Obstetricians and Gynaecologists, private umbilical cord blood banks, which ostensibly provide a personal "spare parts kit" for the baby, produce poorer outcomes than public cord blood banking.

It is true that in some areas of Me Medicine, such as genetically individualised drug regimes for cancer care (technically known as pharmacogenetics), there has been genuine progress. For example, vemurafenib, a drug for aggressive melanoma, was reported in a 2012 New England Journal of Medicine article to extend the lifespan of 1 in 4 patients by seven months if they carry a specific genetic mutation in their cancer.

But only about half of those with the "right" type of tumour responded, and the mutation in question only occurs in about half of such melanomas. What is more, pharmaceutical firms will probably charge more for such drugs than for mass-market ones. They will be expensive, may benefit only a subset of the population and could leave cash-strapped state healthcare systems facing difficult decisions about where to allocate resources.

Follow this link:

*Me* medicine could undermine public health measures

BOSTON--(BUSINESS WIRE)--

Harvard Business Review (HBR) and the New England Journal of Medicine (NEJM) today launched the Leading Health Care Innovation Insight Center, an eight-week online forum dedicated to helping leaders, managers, and other decision makers in health care improve patient outcomes and lower the cost of care.

The Insight Center runs from September 17 through November 15 and offers daily posts, peer-reviewed reports, and interactive content on topics such as leadership, strategy, organizational design, and talent management. Articles will examine specific tactics being applied in health care systems today to reduce costs and improve quality.

As part of the forum, Michael E. Porter, Harvard Business School professor and one of the worlds most respected thinkers on competitive strategy, and Thomas H. Lee, Chief Medical Officer of Press Ganey and former Network President and CEO for Partners Community HealthCare, Inc., will host a webinar on Sept. 24 at 12 p.m. ET to discuss their article from HBRs October issue, The Strategy That Will Fix Health Care.

Were excited to partner with the New England Journal of Medicine to explore how managers and decision makers can transform health care around the world, said Adi Ignatius, HBR Editor in Chief. Our goal is to promote discussion among physicians, health care leaders, clinicians, and policymakers about value and innovation in health care.

The collaborative publishing project between the Journal and the Harvard Business Review comes at a turning point in American health care, said Gregory D. Curfman, M.D., NEJM Executive Editor. Never before have the interests of the health care community and the business community been better aligned.

The Insight Centers advisory board includes distinguished leaders from medicine, business, and academia, among them the CEOs of Cleveland Clinic, Mayo Clinic, and Emory Healthcare.

Visit the Leading Health Care Innovation Insight Center at hbr.org/insights/healthcare or follow it on Twitter at @HBRhealth.

About Harvard Business Review

Harvard Business Reviewis the leading destination for smart management thinking. Through its flagship magazine, 12 international licensed editions, books from Harvard Business Review Press, and digital content and tools published onHBR.org,Harvard Business Reviewprovides professionals around the world with rigorous insights and best practices to lead themselves and their organizations more effectively and to make a positive impact.

More:

Harvard Business Review and the New England Journal of Medicine Launch Online Forum on Health Care Innovation

HARTFORD, Conn.--(BUSINESS WIRE)--

The Tour for Diversity in Medicine will travel the Northeast corridor to introduce medicine and dentistry as a field of advanced study and career path to minority students from September 23-28, 2013. Along with Tour partner the Aetna Foundation, more than 15 doctors, dentists and medical school students from across the country will participate in the program, which will provide full-day, hands-on workshops to undergrad students in six states. For the first time, the Tour will also engage with high school students, in addition to college undergraduates, during the Tours final stop in Washington, D.C.

The Tour will travel 400 miles over six days making six different stops at locations including two historically black colleges and universities. The participating medical professionals will hold conversations with hundreds of potential medical and dental professionals over the course of the week. The Tour for Diversity in Medicines mission is to help diversify the health care profession by giving minority students the advice and tools they will need to pursue medical careers.

Although African Americans, Hispanics and Native Americans compose more than 26 percent of the U.S. population, they represent only six percent of practicing physicians and five percent of dentists, according to the Association of American Medical Colleges (AAMC). In 2011, African-American and Hispanic students made up only 15 percent of all U.S. medical school applicants.1 Yet research shows that patients who receive care from doctors of the same background are more satisfied with their care and more engaged in their treatment.

Our mission is to make a tangible difference in the lives of students and the broader community by offering the vision and real-world strategies to overcome barriers to address the need for greater diversity in the medical profession. Bridging the health-equity gap for under-represented minorities will only happen if our next generation is ready to meet the challenge, said Alden Landry, M.D., co-founder of the Tour for Diversity in Medicine and an emergency department physician at Beth Israel Deaconess Medical Center in Boston. By reaching students early, even at the high school level, and engaging in face-to-face sessions with professionals who come from similar backgrounds, we hope to empower students to consider a career in medicine early on and to imagine whats possible for patients and their communities with a more diverse physician population.

The week of September 23, the Tour for Diversity in Medicine will travel to:

Garth Graham, M.D., M.P.H., president of the Aetna Foundation, said, As our nations population becomes increasingly diverse, we need to ensure that future health care providers reflect the racial and ethnic diversity that will help further positive health outcomes today and for future generations.As the Tours founding sponsor, we are pleased to offer our support to this innovative initiative that takes concrete steps to help under-represented minorities see a path forward to a career in medicine.

Aetna is offering further support to the Tour by hosting a workshop on Monday, September 23 at its Hartford headquarters for more than 100 college students from the University of Connecticut, St. Josephs University, Quinnipiac University and other area educational institutions.

Each university campus tour stop involves a full-day session about the medical school application process, admissions tests, financial aid, interviewing skills and an overview of health disparities. Students interact one-on-one with mentors who will offer personal insights and share their experiences about how to build a successful career in medicine or dentistry. Unique this year, high school students will participate in sessions at Georgetown University School of Medicine to help set them up for college academic success and expose them to courses on topics including, Building Academic Habits, College Readiness 101 and Interactive Healthcare Skills.

Along the way, the enthusiasm weve received from students has propelled us to reach more than 1,400 students in the dozen states weve visited on past Tours. We look forward to tracking these students as they begin their journeys toward a career in medicine, said Kameron Matthews, M.D., J.D., co-founder of the Tour for Diversity in Medicine and medical director of the Division Street site of Erie Family Health Center in Chicago. We volunteer our time and log the miles because we are committed to giving back on behalf of the mentoring we received in our careers. If we are able to spark interest in a career in medicine, this cycle of mentorship has been paid forward again.

See the original post:

Tour for Diversity in Medicine and Aetna Foundation Travel the Northeast to Inspire Minority Students to Pursue ...

BOCA RATON, FL--(Marketwired - Sep 17, 2013) - Modernizing Medicine, the creator of the Electronic Medical Assistant (EMA), a cloud-based specialty-specific electronic medical record (EMR) system, is marking the important role health information technology plays in improving healthcare delivery in America by celebrating National Health Information Technology (NHIT) Week, September 16-20, 2013.

Health information technology improves the quality of healthcare delivery, increases patient safety, decreases medical errors and strengthens the interaction between patients and healthcare providers.

"We have seen our EMA technology help physicians practice medicine more effectively," said Daniel Cane, President and CEO of Modernizing Medicine. "We're harnessing the benefits of medical data to improve clinical outcomes and make medicine more evidence-based in the specialty and sub-specialty markets. Our participation in NHIT Week highlights our commitment to work with our partners and colleagues to better our healthcare system. In addition, we are thrilled that EMA Plastic Surgery and EMA Cosmetic Medical Director Dr. Tim Sayed represents Modernizing Medicine year-round on the HIMSS Electronic Health Record Association Executive Committee."

For additional information about National Health IT Week, visit http://www.healthitweek.org/.

About Modernizing Medicine

Modernizing Medicine is transforming how healthcare information is created, consumed and utilized in order to increase efficiency and improve outcomes. Its product, Electronic Medical Assistant (EMA), is a cloud-based, specialty-specific electronic medical record (EMR) system with a massive library of built-in medical content, designed to save physicians time. Available as a native iPad application or from any web-enabled Mac or PC, EMA adapts to each provider's unique style of practice and is designed to interface with hundreds of different practice management systems. Today, Modernizing Medicine provides specialty-specific offerings for the dermatology, ophthalmology, optometry, orthopedics and plastic and cosmetic surgery markets, and to more than 1,100 physician practices across the country. In 2013 Modernizing Medicine was listed on Forbes' annual ranking of America's Most Promising Companies.

About National Health Information Technology Week

Now in its eighth year, National Health IT Week is a collaborative forum assembling key healthcare constituents -- vendors, provider organizations, payers, pharmaceutical/biotech companies, government agencies, industry/professional associations, research foundations, and consumer protection groups -- working together to elevate national attention to the necessity of advancing health IT. Log onto http://www.healthitweek.org for more information.

Read more from the original source:

Modernizing Medicine Celebrates National Health IT Week September 16-20, 2013